McCarter & English, LLP
Substituted pyrrolopyridines as ATR inhibitors
The disclosure includes compounds of Formula (I) wherein A, W, m, R5, R6, R7, and R8, are defined herein. Also disclosed is a method for treating a neoplastic disease with these compounds.
BlueValley Pharmaceutical LLC
C A A A
C07D A61P A61P A61P
inventional inventional inventional inventional
Xiang
Li